• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Kazakhstan·Energy·KEGC.KZ
Share

KEGOC Stocks

¤ 0Last Updated 03.08.2026

Issuer Rating

Performance

Risk

Recommendation

Sell

¤ 0
Key Takeaways

Risk factor

Profitability factor

Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

03.08.2026 12:16

Concrete or a Presentation: How to Profit from Kazakhstan’s Investments in AI

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

No company description

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

03.08.2026 13:25

Morgan Stanley Expects Korean Stocks to Soar 44% After Their Worst Month Since 2008

03.08.2026 12:16

Concrete or a Presentation: How to Profit from Kazakhstan’s Investments in AI

03.08.2026 11:43

SpaceX's Earnings Report, the Job Market, and Big Pharma: What Investors Can Expect This Week

03.08.2026 11:25

Alibaba has unveiled an AI model comparable to Anthropic's cutting-edge developments

03.08.2026 10:12

Top Stories This Morning: U.S.-Iran Talks, a Major Pharmaceutical Deal, and a Market Correction in Asia

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026